John Sigurd Mjøen Svendsen
Fondatore presso Pharmasum Therapeutics AS
Posizioni attive di John Sigurd Mjøen Svendsen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| University of Tromso | Corporate Officer/Principal | 14/05/2009 | - |
Pharmasum Therapeutics AS
 Pharmasum Therapeutics AS BiotechnologyHealth Technology Pharmasum Therapeutics AS operates as a pharmaceutical company. The firm focuses on the discovery and development of novel human medicines for the treatment of brain diseases, especially neurological diseases. The company was founded by Anders Fugelli and John Sigurd Svendsen is headquartered in Kvaloysletta, Norway. | Direttore/Membro del Consiglio | - | - |
| Fondatore | - | - | |
| Direttore Tecnico/Scientifico/R&S | - | - |
Storia della carriera di John Sigurd Mjøen Svendsen
Precedenti posizioni note di John Sigurd Mjøen Svendsen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Prophylix AS
 Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Direttore/Membro del Consiglio | - | - |
| Massachusetts Institute of Technology | Corporate Officer/Principal | - | - |
| LYTIX BIOPHARMA | Direttore/Membro del Consiglio | 01/01/2003 | - |
| Direttore Tecnico/Scientifico/R&S | 25/06/2013 | 04/09/2013 | |
| Fondatore | 01/01/2003 | - | |
| Corporate Officer/Principal | 04/09/2013 | - |
Formazione di John Sigurd Mjøen Svendsen
| University of Tromso | Doctorate Degree |
Statistiche
Distribuzione geografica
| Norvegia | 5 |
| Stati Uniti | 2 |
Posizioni
| Director/Board Member | 3 |
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| LYTIX BIOPHARMA | Health Technology |
| Aziende private | 2 |
|---|---|
Prophylix AS
Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Health Technology |
Pharmasum Therapeutics AS
Pharmasum Therapeutics AS BiotechnologyHealth Technology Pharmasum Therapeutics AS operates as a pharmaceutical company. The firm focuses on the discovery and development of novel human medicines for the treatment of brain diseases, especially neurological diseases. The company was founded by Anders Fugelli and John Sigurd Svendsen is headquartered in Kvaloysletta, Norway. | Health Technology |
